Global Endorphins Market Outlook 2022

Endorphins are also known as “feel-good” or natural pain relievers. They are produced by the central nervous system and pituitary gland. Endorphins are released in response to stress or pain. They work similarly to a class of drugs called opioids. However, endorphins work similarly to opioid pain reliver, but their result may not dramatic. Besides, they are also released during other activities such as exercise, eating and others activities. Endorphins are also surge during pregnancy. Further, there are various medicinal herbs such as Rhodiola roseal, is known to release beta-endorphins in the brain and also used against an anti-depressant.

The global Endorphins market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Endorphins volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Endorphins market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Endorphins Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins


Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies


By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


By Company
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson